Crb 65 Score Calculator
Assess community-acquired pneumonia severity using CRB-65 criteria without lab tests. Enter values for instant results with step-by-step formulas.
Formula
CRB-65 Score = C + R + B + 65 (each criterion = 1 point, range 0-4)
C = Confusion (new mental confusion, AMTS <= 8). R = Respiratory rate >= 30 breaths/min. B = Blood pressure (systolic < 90 mmHg or diastolic <= 60 mmHg). 65 = Age >= 65 years. Each positive criterion scores 1 point for a maximum of 4.
Worked Examples
Example 1: Low-Risk Outpatient Assessment
Problem: A 45-year-old patient presents with cough, fever, and chest X-ray showing right lower lobe consolidation. The patient is alert and oriented, respiratory rate is 22/min, blood pressure is 130/80 mmHg.
Solution: CRB-65 Criteria Assessment:\nC - Confusion: No (0 points)\nR - Respiratory Rate >= 30: No, RR = 22 (0 points)\nB - Low Blood Pressure: No, BP = 130/80 (0 points)\n65 - Age >= 65: No, age = 45 (0 points)\nTotal CRB-65 Score = 0
Result: Score 0 (Low Risk) | 30-day mortality ~0.9% | Outpatient treatment appropriate
Example 2: High-Risk Hospital Admission
Problem: A 72-year-old patient presents with productive cough for 3 days. The patient is confused and disoriented to time, respiratory rate is 34/min, blood pressure is 85/55 mmHg.
Solution: CRB-65 Criteria Assessment:\nC - Confusion: Yes, disoriented (1 point)\nR - Respiratory Rate >= 30: Yes, RR = 34 (1 point)\nB - Low Blood Pressure: Yes, SBP 85 < 90 (1 point)\n65 - Age >= 65: Yes, age = 72 (1 point)\nTotal CRB-65 Score = 4
Result: Score 4 (High Risk) | 30-day mortality ~31.2% | Urgent admission, consider ICU
Frequently Asked Questions
What is the CRB-65 score and how is it different from CURB-65?
The CRB-65 score is a simplified clinical prediction tool used to assess the severity of community-acquired pneumonia (CAP) in adults. It evaluates four criteria: Confusion, Respiratory rate of 30 or more per minute, low Blood pressure (systolic less than 90 or diastolic 60 or below), and age 65 or older. Unlike the CURB-65 score, the CRB-65 does not require measurement of blood urea nitrogen (BUN), making it ideal for use in primary care, outpatient settings, and emergency departments where laboratory results are not immediately available. The CRB-65 was developed by Bauer and colleagues and has been validated in multiple large studies across different healthcare systems.
How is the CRB-65 score interpreted for clinical decision making?
The CRB-65 score ranges from 0 to 4 points, with each criterion contributing one point. A score of 0 indicates low risk with an estimated 30-day mortality of approximately 0.9 percent, and these patients can typically be managed as outpatients with oral antibiotics. A score of 1 to 2 suggests moderate risk with mortality ranging from 5.2 to 12 percent, and hospitalization should be considered based on overall clinical assessment. A score of 3 to 4 represents high risk with mortality exceeding 31 percent, requiring urgent hospital admission and possible intensive care unit evaluation. The score provides a quick initial assessment but should always be supplemented with clinical judgment.
When should the CRB-65 score be used instead of CURB-65?
The CRB-65 is specifically designed for situations where laboratory testing is not readily accessible, making it the preferred tool in general practice, urgent care clinics, nursing homes, and initial emergency triage before blood work returns. It is endorsed by the British Thoracic Society and the National Institute for Health and Care Excellence (NICE) as a validated bedside assessment tool. The CRB-65 performs comparably to the CURB-65 in predicting 30-day mortality, with studies showing similar area under the receiver operating characteristic curve values. However, when BUN results are available, the CURB-65 may provide slightly better discrimination between risk groups, particularly for identifying patients who need ICU admission.
What defines confusion in the CRB-65 scoring criteria?
Confusion in the CRB-65 score refers to new-onset mental confusion, which is typically assessed using the Abbreviated Mental Test Score (AMTS). A patient scores positive for confusion if the AMTS is 8 or less out of 10, indicating significant cognitive impairment. The AMTS tests orientation (time, place, recognition of persons), memory (recall an address, dates of World War II, current monarch or president), and concentration (counting backward from 20). In practice, clinicians often use a simpler assessment of whether the patient is oriented to person, place, and time, or has any new disorientation. It is important to establish that the confusion is new and not a baseline cognitive state, particularly in elderly patients with pre-existing dementia.
What are the limitations of the CRB-65 score?
The CRB-65 has several important limitations that clinicians should consider. First, it does not account for comorbidities such as COPD, diabetes, heart failure, or immunosuppression, which significantly affect pneumonia outcomes. Second, it may underestimate severity in younger patients with severe sepsis who do not meet the age criterion. Third, the score was primarily validated in European populations and may not perform identically in all demographics. Fourth, vital sign criteria use fixed thresholds that do not account for individual baseline values, such as patients with chronically low blood pressure. Finally, the score does not incorporate oxygen saturation, radiographic findings, or inflammatory markers that may indicate severe disease requiring escalated care.
How does age affect pneumonia severity and the CRB-65 score?
Age is a significant independent predictor of pneumonia mortality, which is why age 65 or older contributes one point to the CRB-65 score. Older adults have higher pneumonia mortality due to declining immune function (immunosenescence), reduced respiratory reserve, increased prevalence of comorbidities, and impaired ability to mount a febrile response that could delay diagnosis. Studies show that 30-day mortality for community-acquired pneumonia is approximately 1 to 2 percent in patients under 65 but rises to 10 to 15 percent in those over 65 and exceeds 25 percent in those over 85. However, the binary age threshold of 65 is a simplification because risk increases continuously with age, and some younger patients with multiple comorbidities may have worse outcomes than healthy older individuals.